News

Clinical Trials Arena17h
ASCO25: Roche’s Itovebi combo reduces risk of death in breast cancer by 33%
In combination with Pfizer’s CDK4/6 inhibitor Ibrance (palbociclib) and anti-oestrogen drug Faslodex (fulvestrant), Itovebi ...
Clinical Trials Arena22h
MINO Labs’ CBD cream offers protective benefits against UVA skin damage
The CBD-based cream reduced UVA damage, preventing nuclear and mitochondrial DNA mutations associated with skin ageing and ...
Clinical Trials Arena19h
ANI Pharmaceuticals initiates Phase IV trial of gel for acute gout flares
ANI Pharmaceuticals has commenced a Phase IV trial to compare two dosage levels of Purified Cortrophin Gel for acute gout ...